Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

NET 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1 Breast 1

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Rituximab 29 Surveys and Questionnaires 25 Blood Specimen Collection 17 Gene Expression Profiling 15 Flow Cytometry 14 Polymerase Chain Reaction 13 Amplified Fragment Length Polymorphism Analysis 13 Microarray Analysis 11 Observation 10 Interviews as Topic 10 Psychiatric Rehabilitation 9 Lenalidomide 9 Immunohistochemistry 9 Cytogenetic Analysis 9 obinutuzumab 8 Watchful Waiting 8 Therapeutics 8 ibrutinib 7 Drug Therapy 7 Cyclophosphamide 7 Bendamustine Hydrochloride 7 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 fludarabine 5 In Situ Hybridization, Fluorescence 5 Immunologic Techniques 5 Data Collection 5 Brentuximab Vedotin 5 Biopsy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Salvage Therapy × Lymphoid × Clear all

NCT07470996 2026-03-13

T-START-NR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡